Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study

  • Bernardo Sousa-Pinto
  • , Aiste Ramanauskaite
  • , Sophia Neisinger
  • , Ellen Witte-Händel
  • , Ana M. Gimenez-Arnau
  • , Carole Guillet
  • , Claudio Alberto S. Parisi
  • , Constance H. Katelaris
  • , Daria Fomina
  • , Désirée Larenas-Linnemann
  • , Elizabeth García
  • , Emek Kocatürk
  • , Frank Siebenhaar
  • , Hermenio Lima
  • , Igor Kaidashev
  • , Iman Nasr
  • , Isabel Ogueta Canales
  • , Ivan Cherrez Ojeda
  • , Jacques Hébert
  • , Jean Bousquet
  • Jonathan A. Bernstein, Jonny Peter, Jorge Sanchez, Jose Ignacio Larco Sousa, Kanokvalai Kulthanan, Karsten Weller, Kiran Godse, Krzysztof Rutkowski, Lasma Lapina, Laurence Bouillet, Leo Lianyi Han, Luis Felipe Ensina, Margarida Gonçalo, Markus Magerl, Martijn van Doorn, Martin Metz, Maryam Khoshkhui, Michihiro Hide, Murat Türk, Nataļja Kurjāne, Niall Conlon, Pascale Salameh, Pavel Kolkhir, Riccardo Asero, Roman Stepanenko, Sabine Altrichter, Sara Gil-Mata, Simon Francis Thomsen, Torsten Zuberbier, Vladyslav Tsaryk, Young Min Ye, Zenon Brzoza, Zuotao Zhao, Marcus Maurer
  • University of Porto
  • Charité – Universitätsmedizin Berlin
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
  • Pompeu Fabra University
  • University of Zurich
  • Hospital Italiano de Buenos Aires
  • Western Sydney University
  • Moscow Healthcare Department
  • Sechenov First Moscow State Medical University
  • Astana Medical University
  • Center of Excellence in Asthma and Allergy Larenas Hospital Médica Sur
  • Universidad de los Andes Colombia
  • Koc University
  • McMaster University
  • Poltava State Medical University
  • Royal Hospital Oman
  • Pontificia Universidad Católica de Chile
  • University Dermatological Center (DermaCDU)
  • Rancagua Regional Hospital
  • Université Laval
  • University of Cincinnati
  • University of Cape Town
  • Universidad de Antioquia
  • Clínica San Felipe
  • Mahidol University
  • D Y Patil Group
  • Guy's and St Thomas' NHS Foundation Trust
  • Riga Stradins University
  • CHU de Grenoble
  • Fudan University
  • Universidade Federal de São Paulo
  • University of Coimbra
  • Erasmus University Rotterdam
  • Mashhad University of Medical Sciences
  • Hiroshima University
  • Erciyes University
  • Paula Stradina Clinical University Hospital
  • Trinity College Dublin
  • Lebanese American University
  • University of Nicosia Medical School
  • Institut National de Santé Publique d'Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB)
  • Clinica San Carlo
  • Bogomolets National Medical University
  • Johannes Kepler University Linz
  • University of Copenhagen
  • Ajou University
  • University of Opole
  • Peking University

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

13 Citas (Scopus)

Resumen

Background: CRUSE® is an app that allows patients with chronic spontaneous urticaria (CSU) to monitor their daily disease activity through the use of visual analogue scales (VASs). We aimed to determine the concurrent validity, reliability, responsiveness and minimal important difference (MID) of CRUSE® VASs. Methods: We evaluated the properties of three daily VASs: VAS for how much patients were affected by their CSU (‘VAS urticaria’), VAS for the impact of urticaria on work/school productivity (‘VAS productivity’) and the VAS of EQ-5D. Concurrent validity was assessed by measuring the association between each VAS and the Urticaria Activity Score (UAS). Intra-rater reliability was determined based on the data of users providing multiple daily questionnaires within the same day. Test–retest reliability and responsiveness (ability to change), respectively, were tested in clinically stable and clinically unstable users. MIDs were determined using distribution-based methods. Results: We included 5938 patients (67,380 days). Concurrent validity was high, with VAS urticaria being more strongly associated with the UAS score than the remaining VASs. Intra-rater reliability was also high, with intraclass correlation coefficients (ICC) being above 0.950 for all VASs. Moderate-high test–retest reliability and responsiveness were observed, with reliability ICC being highest for VAS EQ-5D and responsiveness being highest for VAS urticaria. The MID for VAS urticaria was 17 (out of 100) units, compared to 15 units for VAS productivity and 11 units for VAS EQ-5D. Conclusion: Daily VASs for CSU available in the CRUSE® app display high concurrent validity and intra-rater reliability and moderate-high test–retest reliability and responsiveness.

Idioma originalInglés
Páginas (desde-hasta)750-761
Número de páginas12
PublicaciónAllergy: European Journal of Allergy and Clinical Immunology
Volumen80
N.º3
DOI
EstadoPublicada - mar 2025

Huella

Profundice en los temas de investigación de 'Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study'. En conjunto forman una huella única.

Citar esto